【レポートの概要(一部)】
1 Table of contents
1 Table of contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Pharmaceuticals & Healthcare, Global, Deal Summary, 7
2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, March 2013 7
2.2 Pharmaceuticals & Healthcare, Global, Major Deals, March 2013 9
2.2.1 Medtronic Completes Public Offering of Notes for $3 Billion 9
2.2.2 Lundbeck Enters into Licensing Agreement with Otsuka Pharma for Lu AE58054 9
2.2.3 Edison Pharma Enters Into Licensing Agreement with Dainippon Sumitomo Pharma for EPI-743 and EPI-589 10
2.2.4 Sinopharm Announces Private Placement of Shares for $525 Million 10
2.2.5 AstraZeneca Enters into Co-Development Agreement with Moderna Therapeutics for Messenger RNA Therapeutics 10
2.3 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, March 2013 11
2.4 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, March 2013 12
3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type 13
3.1 Pharmaceuticals & Healthcare, Global, M&A, March 2013 13
3.1.1 Top M&A Deals in March 2013 14
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy Area, October 2012–March 2013 15
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, March 2013 16
3.2.1 Top Equity Offering Deals in March 2013 17
3.2.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, October 2012– March 2013 18
3.3 Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital Deals, March 2013 19
3.3.1 Top PE/VC Deals in March 2013 20
3.3.2 Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area, March 2013 21
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, March 2013 22
3.3.4 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, October 2012– March 2013 24
3.3.5 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, October 2012– March 2013 25
4 Pharmaceuticals & Healthcare, Global, Partnership Deals, March 2013 26
4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, March 2013 26
4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, October 2012– March 2013 27
4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Values (US$ m), March 2013 28
4.3.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals by Payment Mode, March 2013 29
4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), October 2012– March 2013 30
4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Number Of Deals, October 2012– March 2013 31
4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Deal Values (US$ m), October 2012– March 2013 32
4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), October 2012– March 2013 33
5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, March 2013 34
5.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, March 2013 34
5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), March 2013 35
5.2.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Deal Value, March 2013 36
5.2.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, March 2013 36
5.2.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Total Milestone Payment, March 2013 37
5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Values (US$ m), October 2012– March 2013 38
5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payments and Milestone Payments (US$ m), October 2012– March 2013 39
5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Values (US$ m), October 2012– March 2013 40
5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Upfront Payments and Milestone Payments (US$ m), October 2012– March 2013 42
6 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 43
6.1 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, March 2013 43
6.1.1 Central Nervous System – Deals of the Month 44
6.2 Pharmaceuticals & Healthcare, Global, Oncology Deals, March 2013 45
6.2.1 Oncology – Deals of the Month 46
6.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, March 2013 47
6.3.1 Infectious Diseases – Deals of the Month 48
6.4 Pharmaceuticals & Healthcare, Global, Immunology Deals, March 2013 49
6.4.1 Immunology – Deal of the Month 50
6.5 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, March 2013 51
6.5.1 Cardiovascular – Deal of the Month 52
6.6 Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals, March 2013 53
6.6.1 Gastrointestinal – Deal of the Month 54
6.7 Pharmaceuticals & Healthcare, Global, Metabolic Disorder Deals, March 2013 55
6.7.1 Metabolic Disorders – Deal of the Month 56
7 Deal Summary by Geography 57
7.1 Pharmaceuticals & Healthcare, North America Deals, March 2013 57
7.1.1 North America – Deals of the Month 58
7.2 Pharmaceuticals & Healthcare, Europe, Deals, March 2013 59
7.2.1 Europe – Deals of the Month 60
7.3 Pharmaceuticals & Healthcare, Asia-Pacific, Regional Deals, March 2013 61
7.3.1 Asia-Pacific – Deals of the Month 62
7.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, March 2013 63
7.4.1 Rest of the World – Deals of the Month 64
8 Pharmaceuticals & Healthcare, Global, Top Financial Advisors 65
8.1 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, October 2012– March 2013 65
8.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, October 2012– March 2013 66
9 Further Information 67
9.1 Methodology 67
9.2 About GlobalData 67
9.3 Contact Us 68
9.4 Disclosure information 68
9.5 Disclaimer 68
【レポート販売概要】
■ タイトル:事業提携・ライセンシング・投資・M&A動向:March 2013(製薬業界)■ 英文:Partnerships, Licensing, Investments and M&A Deals and Trends for March 2013 in Pharmaceuticals
■ 発行日:2013年4月12日
■ 調査会社:GlobalData
■ 商品コード:GDATA403160765
■ 調査対象地域:グローバル
- ランサムウェア対策の世界市場予測(~2021):ソリューション別(ランサムウェア対策ソフトウェア、セキュアウェブゲートウェイ、アプリケーションコントロール、IDS/IPS、脅威インテリジェンス)、サービス別、アプリケーション別、導入別、企業規模別、産業別、地域別The ransomware protection market size is expected to grow from USD 8.16 Billion in 2016 to USD 17.36 Billion by 2021, at a Compound Annual Growth Rate (CAGR) of 16.3% during the forecast period. The major growth drivers of the market include rise in phishing attacks and security breaches and emergence of Ransomware-as-a-Service (RaaS) model, through which cybercriminals are reaping billions of dol …
- 先進創傷被覆材の世界市場分析および予測MediPoint: Advanced Wound Dressings - Global Analysis and Market Forecasts Summary Advanced wound dressings are used to treat a variety of acute wounds, such as burns, cuts, lacerations and abrasions, chronic wounds, such as a diabetic foot ulcers, pressure ulcers and leg ulcers, and surgical wounds sustained during various procedures. Advanced dressings are a steadily growing segment of the wound …
- ポリウレタンの世界市場予測(~2021):原料別(ジフェニルメタンジイソシアネート(MDI)、トルエンジイソシアネート(TDI)、ポリオール)、製品別(コーティング、接着剤・密閉剤、軟質・硬質発泡体、エラストマー)、エンドユーザー別(ビル・建設、自動車・輸送、寝具・家具)“The global market for polyurethane is projected to grow at a CAGR of 5.6% from 2016 to 2021”The global polyurethane market is projected to reach USD 56.76 billion by 2021, at a CAGR of 5.6%, from 2016 to 2021. The growing middle class with increasing disposable incomes, and rising urbanization supplemented strongly by investments in infrastructure is driving the global polyurethane market. The ri …
- 世界の風疹検査市場The report presents a detailed analysis of the Rubella diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Rubella definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - Commerc …
- 放射線検出用素材の世界市場2015-2022Growth in the demand for radiation detection, especially for homeland security and medical applications, is driving the need for radiation detection materials that can provide sufficient performance at the right price. Increased interest in mobile radiation detection for security and military applications places more emphasis on materials that can reliably distinguish between naturally occurring a …
- 医療レポート:Endometriosis-疫学予測(~2022)EpiCast Report: Endometriosis - Epidemiology Forecast to 2022 Summary Endometriosis is an estrogen-dependent disorder characterized by growth and appearance of endometrial cells or tissues in locations outside the uterus, which results in a series of chronic inflammatory reactions leading to scarring of tissues and adhesions of fibrous tissues in the pelvic region. Globally, the disease affects up …
- ポリウレタン(PU)の世界市場分析:製品別(硬質フォーム、軟質フォーム、塗料、接着剤およびシーラント、エラストマー)、エンドユーザー別(家具・インテリア、建築、家電家具、自動車、靴、包装)、セグメント予測、2014-2025The global polyurethane (PU) market is anticipated to reach USD 105.2 billion by 2025, according to a new report by Grand View Research, Inc. urethane polymers are increasingly being utilized to address consumer needs in health, convenience and sustainability by means of applications such as adhesives, coatings, and insulation materials among others. Thermoplastic polyurethane (TPUs) are widely ut …
- スモールセル及びWi-FiオフロードAs mobile data proliferates so too does the demand for capacity and coverage. Many options exist to cope with data surge. Small cell deployment and Wifi offloading are the main ones. Small cells give the opportunity to come closer to the user and to offer a better coverage, indoors or outdoors at low cost. Despite remaining technological hurdles, Wifi is a heavily deployed and cost-effective solut …
- コンテンツデリバリネットワーク(CDN)市場の主要ベンダー分析、動向及び展望(2014-2019)The digital content market is poised to reach a new stage in its evolution with the coming pipeline of next generation applications and solutions. Content consumption among consumers is exploding due to many factors including higher bandwidth, low cost digital devices, and smart devices (phones, tablets, and wearable wireless) devices. Content Delivery Networks (CDN) provide solutions for efficien …
- 船舶用プロペラの世界市場:可変ピッチ式、固定ピッチ式、ダクトプロペラThe marine propeller market is estimated to be USD 4.61 Billion in 2015 and is projected to reach USD 5.06 Billion by 2020 at a CAGR of 1.88%. The market is driven by the growth in global trade and shipbuilding industry in countries such as China, Japan and South Korea. There is also an increase in naval threats and disputes, especially in the APAC region, which has led to the rise in naval fleet …
- 血液凝固分析装置の世界市場The global coagulation analyzers market is estimated to grow at a lower CAGR in developed countries; however, it is expected to witness high growth in emerging countries such as China, India, and Brazil in the next five years. Growth in the coagulation analyzers market is driven by factors such as increasing adoption of automated hemostasis instruments by diagnostics laboratories, development of h …
- ポリフッ化ビニリデン(PVDF)塗料の世界市場The global PVDF coating market report defines and segments the concerned market with analysis and forecast of revenue. This market was valued at $176.5 million in 2014 and is projected to reach $241.4 million by 2019, at a CAGR of 6.5% during the forecast period 2014 to 2019. By consumption, this market, was at a volume of 7,742.6 tonnes in 2014 and is projected to reach a volume of 10,137.1 tonne …
- 原発性硬化性胆管炎(Primary Sclerosing Cholangitis)の治療薬パイプライン動向(2015年上半期版)Primary Sclerosing Cholangitis - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Primary Sclerosing Cholangitis - Pipeline Review, H1 2015’, provides an overview of the Primary Sclerosing Cholangitis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Primary Sclerosing Cholangitis, complete with comparative analysis at various stage …
- 硬質プラスチック:世界市場動向2011-2016(Rigid Plastics – A Global Market Watch, 2011 – 2016)Global Market Watch: The rigid plastics market is expected to reach US$272.9 billion worth by 2016 primarily supported by the segments: types - caps & closures and pails and resins ? Polyethylene Tetraphthalate (PET) and Poly Vinyl Chloride (PVC). Globally, Polyethylene (PE) and Polypropylene (PP) together account for approximately 46% of the market are expected to support the plastics industry go …
- Anderson Energy Ltd.:石油・ガスバリューチェーン分析レポート2013Anderson Energy Ltd. Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Anderson Energy Ltd." Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Anderson Energy Ltd.”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report exam …